إعلان
إعلان
IPHA
Innate Pharma S.A. ADS
1.79
USDبرعاية
+0.05
+2.87%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
1.80
+0.01
+0.50%
تقارير أرباح IPHA
النسبة الإيجابية المفاجئة
IPHA تفوق 0 من 1 آخر التقديرات.
%
التقرير التالي
بيانات التقرير القادم
٢٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$2.17M
/-$0.12
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/--
Innate Pharma S.A. ADS earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, IPHA reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.12 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.98 مليون, with a --% difference. The market reacted with a -5.21% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 2 المحللين forecast an EPS of -0.12 USD, with revenue projected to reach 2.17 مليون USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Innate Pharma S.A. ADS's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Innate Pharma S.A. ADS reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Innate Pharma S.A. ADS's Q3 2025 earnings?
The stock price moved down -5.21%, changed from $1.92 before the earnings release to $1.82 the day after.
When is Innate Pharma S.A. ADS expected to report next?
The next earning report is scheduled for ٢٦ مارس ٢٠٢٦.
What are the forecasts for Innate Pharma S.A. ADS's next earnings report?
Based on 2
المحللين, Innate Pharma S.A. ADS is expected to report EPS of -$0.12 and revenue of $2.17M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان